跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rosufen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rosufen
Approved
STANDARD
Rosufen
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8e62d9e7ff78b399
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
8e62d9e7ff78b399
Drug Approval Philippines Name
Rosufen
Product Name
Rosufen
Registration Number
DR-XY48235
Brand Name
Rosufen
Generic Name
Rosuvastatin (as calcium) + Fenofibrate
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg/160 mg
Manufacturer
Ajanta Pharma Limited
Importer
Ajanta Pharma Philippines, Inc.
Distributor
Ajanta Pharma Philippines, Inc.
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
27 July 2022
Expiry Date
27 July 2027
Pharmacologic Category
Lipid Modifying Agent
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8e62d9e7ff78b399
Type
Standard
Back to Philippines FDA Approvals